cancer news

Obese patients with colon cancer are at greater risk for death or recurrent disease compared to those who are within a normal weight range, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia.

UT Southwestern Medical Center researchers have found that a naturally occurring protein — transforming growth factor beta1 (TGF-ß1) — which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure.

Bentley Motors is staging an art auction at Bonhams to raise money for The Christie, a cancer hospital in Manchester.

Two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukemia.

Often in the fight against cancer, researchers are not limited by their ingenuity, but the resources available to make research effective.

Siemens Healthcare is expanding its portfolio for cancer therapy by partnering with IMPAC Medical Systems, Inc. (IMPAC) which includes an extension of its software distribution agreement to 2016 and adding the MOSAIQÒ software to its oncology portfolio.

Factbook Provides Authoritative Industry Metrics For The Key Stages In Drug Development

A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system.

Researchers from the Children’s Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered how to turn off a certain receptor that promotes the growth of leukemia cells. The pre-clinical study was presented today in a platform session at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO).

HP today announced that the Almac Group, a global pharmaceutical services provider based in Ireland, has used HP software to reduce the time required to put new drugs through clinical trials.

New data and analyses from a long-running study of cancer survival in Europe have shown that the number of people actually cured of cancer – rather than just surviving for at least five years after diagnosis – is rising steadily.

For orthopaedic researcher Joyce Keyak, Ph.D., finding ways to battle breast cancer is a personal as well as a professional mission. Her cousin died from the disease several years ago. Dr. Keyak still remembers the incredible pain her cousin experienced when the cancer spread to her spine.

St. Jude scientists' findings in ataxia telangiectasia-like disease and Nijmegen breakage syndrome offer insight into the links between brain disease and cancer vulnerability in people carrying the diseases

Using new technologies that make it easier to sequence the human genome, researchers at the University of Michigan Comprehensive Cancer Center have identified a series of genes that become fused when their chromosomes trade places with each other.

An international research team led by Tim Nilsen, Ph.D., a professor of medicine and biochemistry and the director of the School of Medicine's Center for RNA Molecular Biology, has discovered an unexpected mechanism governing alternative splicing, the process by which single genes produce different proteins in different situations.

Imaging study is one of the first to analyze influence of multiple genes

A small antibody fragment that is highly effective in neutralizing the human immunodeficiency virus (HIV) by preventing the virus from entering cells has been identified by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced today that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation's unique drug product for children with Ewing's Sarcoma cancer.

The American Association for Cancer Research is accepting applications for grants supporting pancreatic cancer research.